Comparison of SpectraCell RA Typing and Multilocus Sequence Typing for Extended-Spectrum-β-Lactamase-Producing Escherichia coli

被引:6
|
作者
Overdevest, I. T. M. A. [1 ,3 ]
Heck, M. [2 ]
van der Zwaluw, K. [2 ]
Willemsen, I. [3 ]
van de Ven, J. [3 ]
Verhulst, C. [3 ]
Kluytmans, J. A. J. W. [1 ,3 ,4 ]
机构
[1] St Elizabeth Hosp, Dept Med Microbiol & Immunol, Tilburg, Netherlands
[2] Natl Inst Publ Hlth & Environm Protect, RIVM, NL-3720 BA Bilthoven, Netherlands
[3] Amphia Hosp, Dept Med Microbiol & Infect Control, Breda, Netherlands
[4] VUmc Univ Med Ctr Amsterdam, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands
关键词
D O I
10.1128/JCM.01443-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Multilocus sequence typing (MLST) is one of the most reliable methods for typing of Escherichia coli, including extended-spectrum-beta-lactamase-producing E. coli (ESBL-EC). We investigated the performance of a new typing method, SpectraCell RA (River Diagnostics, Madison, WI), in comparison on MLST on a well-defined collection of ESBL-EC isolates obtained from chicken meat and humans. Ninety-two ESBL-EC isolates obtained from meat and 59 ESBL-EC isolates obtained from human rectal swabs and clinical blood cultures were typed using MLST and SpectraCell RA. The sensitivity and specificity of SpectraCell RA were calculated, using MLST as a reference method. Subsequently, the results of SpectraCell RA were used to determine the relatedness of ESBL-EC isolates from chicken and humans. Using MLST as the gold standard, the performance of SpectraCell RA was evaluated for 3 different cutoff values: 0.99975, 0.99955, and 0.99935. Depending on the cutoff value, the sensitivity was mediocre to unacceptably low, with values of 9.4%, 43.9%, and 66.7%, respectively. When sensitivity increased, the specificity decreased rapidly, from 95.6% to 69.8% and 34.4%, respectively. Also, the number of clusters containing both human and meat samples varied from 0 (0.0%) to 14 (38.9%). Our study shows that SpectraCell RA is not a suitable typing method for ESBL-EC when evaluating relationships of ESBL-EC at the population level.
引用
收藏
页码:3999 / 4001
页数:3
相关论文
共 50 条
  • [1] Rapid Typing of Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae Isolates by Use of SpectraCell RA
    Willemse-Erix, Diana
    Bakker-Schut, Tom
    Slagboom-Bax, Femke
    Jachtenberg, Jan-willem
    Lemmens-den Toom, Nicole
    Papagiannitsis, Costas C.
    Kuntaman, Kuntaman
    Puppels, Gerwin
    van Belkum, Alex
    Severin, Juliette A.
    Goessens, Wil
    Maquelin, Kees
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (04) : 1370 - 1375
  • [2] Extended-Spectrum-β-Lactamase-Producing Escherichia coli as Intestinal Colonizers in the German Community
    Valenza, Giuseppe
    Nickel, Silke
    Pfeifer, Yvonne
    Eller, Christoph
    Krupa, Elzbieta
    Lehner-Reindl, Verena
    Hoeller, Christiane
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1228 - 1230
  • [3] Phylogenetic Characterization and Multilocus Sequence Typing of Extended-Spectrum Beta Lactamase-Producing Escherichia coli from Food-Producing Animals, Beef, and Humans in Southwest Nigeria
    Adefioye, Olusolabomi J.
    Weinreich, Joerg
    Roediger, Stefan
    Schierack, Peter
    Olowe, Olugbenga Adekunle
    [J]. MICROBIAL DRUG RESISTANCE, 2021, 27 (01) : 111 - 120
  • [4] Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread
    Suzuki, Satowa
    Shibata, Naohiro
    Yamane, Kunikazu
    Wachino, Jun-ichi
    Ito, Kenitiro
    Arakawa, Yoshichika
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 72 - 79
  • [5] Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-β-lactamase-producing Escherichia coli
    Krueger, Wolfgang A.
    Kempf, Volkhard A. J.
    Peiffer, Manou
    Nagele, Udo
    Unertl, Klaus E.
    Schroeder, Torsten H.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (02) : 817 - 820
  • [6] Fosfomycin susceptibility among extended-spectrum-β-lactamase-producing Escherichia coli in Nottingham, UK
    Chislett, R. J.
    White, G.
    Hills, T.
    Turner, D. P. J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (05) : 1076 - 1077
  • [7] Multidirectional dynamic model for the spread of extended-spectrum-β-lactamase-producing Escherichia coli in the Netherlands
    Costa, Eduardo de Freitas
    Hagenaars, Thomas J.
    Dame-Korevaar, Anita
    Brouwer, Michael S. M.
    de Vos, Clazien J.
    [J]. MICROBIAL RISK ANALYSIS, 2022, 22
  • [8] Extended-spectrum β-lactamase-producing Escherichia coli
    Sloth, Louise B.
    Hargreaves, Sally
    Nellums, Laura B.
    Nielsen, Rikke T.
    Norredam, Marie
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 405 - 405
  • [9] Multilocus sequence typing compared to PFGE for molecular typing of extended spectrum beta-lactamase-producing Klebsiella pneumoniae isolates
    Elhani, Dalele
    Ben Slama, Karim
    Bakir, Leila
    Boudabous, Abdellatif
    Aouni, Mahjoub
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 2011, 69 (06) : 742 - 744
  • [10] Duration of Stool Colonization in Healthy Medical Students with Extended-Spectrum-β-Lactamase-Producing Escherichia coli
    Li, Bin
    Zhong, Yang
    Fu, Xiao-chun
    Qiu, Yi-hui
    Wang, Si-Ying
    Yang, A-juan
    Huang, Xin-hong
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4558 - 4559